ClinicalTrialsFinder

Relapsed/Refractory Hematological Malignancies Clinical Trials in Ningbo, Zhejiang

1 recruitingNingbo, Zhejiang, China

Showing 1–1 of 1 trials

Recruiting
Phase 1

Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies

LymphomaLeukemiaMyeloma+1 more
The Affiliated People's Hospital of Ningbo University10 enrolled1 locationNCT05528887